Intra‐neural administration of fractalkine attenuates neuropathic pain‐related behaviour
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
There is increasing evidence that a number of cytokines and their receptors are involved in the processes that lead to the development and maintenance of neuropathic pain states. Here we demonstrate that levels of CX3CR1 (the receptor for the chemokine fractalkine) mRNA in lumbar dorsal root ganglia (DRG) increase 5.8‐fold 7 days after sciatic nerve axotomy, and 1.7‐ and 2.9‐fold, 3 and 7 days respectively, after the spared nerve injury (SNI) model of neuropathic pain. In contrast, no significant change in the levels of fractalkine mRNA is apparent in the DRG after axotomy or SNI. The increase in CX3CR1 mRNA is paralleled by a 3.9‐ and 2.1‐fold increase in the number of CX3CR1‐positive macrophages in the DRG 7 days after axotomy and SNI, respectively. Expression of CX3CR1 in macrophages is also markedly increased in the sciatic nerve proximal to site of injury, by 25.7‐fold after axotomy and 16.2‐fold after SNI, 7 days after injury. Intra‐neural injection into the sciatic nerve of 400 ng or 100 ng of fractalkine in adult 129OlaHsd mice significantly delayed the development of allodynia for 3 days following SNI. Further, CX3CR1 knockout (KO) mice display an increase in allodynia for three weeks after SNI compared to strain‐matched Balb/c controls. Taken together, these results suggest an anti‐allodynic role for fractalkine and its receptor in the mouse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013 · cited 6×
“1997), with fractalkine being constitutively expressed by neurons and CX3CR1 predominantly, but not exclusively, by microglia (Bazan et al. 1997; Nishiyori et al. 1998; Tarozzo et al. 2003), and it has been suggested that fractalkine might act as a specific signal between neurons and glia (Harrison et al.”
BackgroundInfluentialControl of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531 · cited 2×
“…cells in the spinal cord most likely represent resident microglia as previously described in the rat (Verge et al. 2004; Lindia et al. 2005; Cardona et al. 2006), though it is possible that invading peripheral macrophages may also contribute to the observed staining, as suggested by Hu et…”
BackgroundMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476
Heritability of nociception I: Responses of 11 inbred mouse strains on 12 measures of nociception
Mogil, J. S., Wilson, S. G., Bon, K., Eun Lee, S., Chung, K., Raber, P., Pieper, J. O., Hain, H. S., Belknap, J. K., Hubert, L., et al. (1999) · Pain · doi:10.1016/s0304-3959(98)00197-3 · Cited by 656
Expression of CX 3 CR1 chemokine receptors on neurons and their role in neuronal survival
Meucci, O., Fatatis, A., Simen, A. A., & Miller, R. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090017497 · Cited by 385 · cited 2×
“Both forms of fractalkine activate CX3CR1 (Imai et al. 1997; Combadière et al. 1998b; Harrison et al. 1998; Meucci et al. 2000).”
BackgroundChemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity
Limatola, C., Lauro, C., Catalano, M., Ciotti, M. T., Bertollini, C., Di Angelantonio, S., Ragozzino, D., & Eusebi, F. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.03.023 · Cited by 153 · cited 2×
“2006), neuroprotection (Limatola et al. 2005), microglial cell migration (Lauro et al.”
Background
Cited by
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Self-citationRamesh, G., MacLean, A. G., & Philipp, M. T. (2013) · Mediators of Inflammation · doi:10.1155/2013/480739 · Cited by 639
“The activation of fractalkine-CX3CR1 has been shown to attenuate peripheral nerve injury-induced neuropathic pain [240].”
BackgroundChemokines, neuronal–glial interactions, and central processing of neuropathic pain
Gao, Y.-J., & Ji, R.-R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.002 · Cited by 627
Austin, P. J., & Moalem-Taylor, G. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.013 · Cited by 607
Chemokines in neuron–glial cell interaction and pathogenesis of neuropathic pain
Zhang, Z.-J., Jiang, B.-C., & Gao, Y.-J. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2513-1 · Cited by 315
Metadata
- Authors
- Holmes, F. E., Arnott, N., Vanderplank, P., Kerr, N. C. H., Longbrake, E. E., Popovich, P. G., Imai, T., Combadière, C., Murphy, P. M., & Wynick, D.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2008-07
- Volume
- 106
- Issue
- 2
- Pages
- 640-649
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2001743906
- Cited by
- 42
- References
- 6
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intra‐neural administration of fractalkine attenuates neuropathic pain‐related behaviour. https://app.cochat.ai/papers/10.1111/j.1471-4159.2008.05419.x
- The paper
- Holmes, F. E., Arnott, N., Vanderplank, P., Kerr, N. C. H., Longbrake, E. E., Popovich, P. G., Imai, T., Combadière, C., Murphy, P. M., & Wynick, D. (2008). Intra‐neural administration of fractalkine attenuates neuropathic pain‐related behaviour. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2008.05419.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.